TNFSF11 and cancer: After reaching the bone, cancer cells secrete PTHrP, which triggers the osteoblast cells to release RANKL and simultaneously inhibit RANKL antagonist osteoprotegerin (OPG) with other growth factors, including TGF-β, and endothelin-1 (ET0-1).